Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/NovImmune

NovImmune

Series A
Plan-les-Ouates, SwitzerlandFounded 1998May 2000
Healthtech

NovImmune raised €15M in a Series A round in May 2000. The company is based in Plan-les-Ouates, Switzerland. Investors in the round: LODH Immunology Fund, Novartis Venture Fund. Data as of Nov 2026.

← NovImmune
Amount raised
€15M
€15,410,017
Native amount
14,000,000 USD
Stage
Series A
series a
Investors
2

Provenance & confidence

Unverified
Amount
14,000,000 USD
ECB-at-date → €15M · rate 0.9085 on 2000-04-28
High confidence
Source

No source on record — unverified.

Unverified

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

2 named
LODH Immunology FundNovartis Venture Fund
Date
May 2000
Round type
series a
Amount (EUR)
€15M

Other rounds

same company